TODAY : Monday, 21 April 2025
Code
INAF
Title
PT. Indofarma Tbk
Address
Head Office:
Address:Jl. Indofarma No. 1 Cikarang Barat
Bekasi 17530 - Jawa Barat
Phone:(021) 8832 3971/75; (021) 8590 8349/50
Fax:(021) 8832.3972 - 73; (021) 857 4503
E-mail:corsec@indofarma.id; headoffice@indofarma.id
Website:www.indofarma.id
Commercial Office:
Plaza Bank Bumi Daya, 12Ath & 14th Floor
Jl. Imam Bonjol No.61 - Jakarta 
Phone:(021) 3983 4030
Fax:(021) 3983 4031
E-mail:
Website:
Background

The Company engage activities :

a. Producing pharmaceutical raw and indirect materials, and chemical materials including agrochemical by itself or under license or contract with other parties

b. Producing of finished goods such as essential medicine, generic medicine, branded medicine, traditional medicine, cosmetics, medical devices, diagnostics and contraceptives. The Company also produces food products or any those related with health care and health improvement including animal food products. The Company produces such goods by itself or under license or contract with other parties.

c. Producing packaging materials, machinery and equipment and infrastructure related to pharmaceutical industry or other industries.
Business cp product

The Company engage activities :

a. Producing pharmaceutical raw and indirect materials, and chemical materials including agrochemical by itself or under license or contract with other parties

b. Producing of finished goods such as essential medicine, generic medicine, branded medicine, traditional medicine, cosmetics, medical devices, diagnostics and contraceptives. The Company also produces food products or any those related with health care and health improvement including animal food products. The Company produces such goods by itself or under license or contract with other parties.

c. Producing packaging materials, machinery and equipment and infrastructure related to pharmaceutical industry or other industries.
Subsidiary affiliation
SubsidiariesDomicileBusiness%
PT Indofarma Global MedikaJakartaDistribution and trading of pharmaceutical products99.99
Commissioners
President Commissioner: Laksono Trisnantoro
CommissionerDidi Agus Mintadi
Independent Commissioner: Teddy Wibisana
Independent Commissioner: Achmad Ghufron Sirodj
Per 30 Sep 2023
Directors
President Director: Agus Heru Darjono
Director: Ariesta Kurniawan
DirectorJejen Nugraha
Director: Kamelia Faisal
Per 30 Sep 2023
Underwriter
PT. Bahana Securities (Representative - Affiliated)
PT. Bhakti Capital Indonesia
PT. Trimegah Securities
Amantara Securities, Andalan Artha Advisindo Sec., Bali Sec., Bapindo Bumi Sekuritas (Affiliated)
BNI Securities
Share registrar
PT. Datindo Entrycom
Share holders
ShareholdersShares%
- PT Bio Farma (Persero)249999999980.66
- PT ASABRI (Persero)2275338507.34
- Negara Republik Indonesia10
- Public37173365011.99
As of Sep 30, 2023
History stocks

Type of ListingDatePrice## of SharesTotal Listed Shares

IPO @Rp. 25017-Mar-20011005968750003096875000

Option Conversion26-Aug-200210023925003099267500
Other infos

Created date
2023-11-03 14:28:36
Revised date
2023-11-03 14:28:36
Finance
 
PT. Indofarma Tbk
 
2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013,
Financial Statetment Date
Fiscal Year Ends
Months Covered in Income St
 
Summary Covered in Income St
Cash and Cash Equivalents
Receivables
Inventories
Current Assets
Fixed Assets
Other Assets
Non Current Assets
Total Assets
Current Liabilities
Longterm Liabilities
Total Liabilities
Authorized
Paid-up Capital
Par Value
Paid-up Capital Shares
Retained Earnings
Total Equity
Minority Interest
 
Summary of Income Statement
Total Sales
Cost of Good Sold
Gross Profit
Operating Profit
Other Income
Earning Before Tax
Tax
Net Income
Close Price
 
Per Share Data (Rp)
Eps (annualized)
Book Value
 
Financial Ratios
Debt Equity Ratio (X)
Roa(%)
Roe(%)
Npm(%)
Opm(%)
Gross Profit Margin (%)
Total Assets Turnover
 
Cash Flow
CF from Operation Activities
CF from Investing Activities
CF from Financing Activities
Net Increase in Cash & Cash Equivalent
Cash & Cash Equivalent at Beginning of the Year
Cash & Cash Equivalent at The End of the Year
2013-12-31 2013-09-30 2013-06-30 2013-03-31
Dec Dec Dec Dec
12 9 6 3
 
 
121,432,026.24 40,873,166.27 29,193,376.68 64,541,814.90
285,853,171.96 307,091,600.06 234,074,393.05 204,237,209.98
236,417,397.36 276,612,241.88 250,567,491.72 196,538,759.09
848,840,281.01 822,356,478.59 710,296,837.95 663,918,676.66
367,912,766.51 364,474,074.76 355,502,714.66 349,522,010.97
8,581,666.21 8,688,613.40 8,825,560.58 8,917,507.77
0.00 0.00 0.00 0.00
1,294,510,669.20 1,274,302,645.63 1,142,498,618.58 1,088,995,673.83
670,902,756.54 531,256,912.26 336,880,500.74 280,176,240.13
32,814,544.77 158,349,910.48 169,054,328.43 169,683,094.92
703,717,301.31 689,606,822.74 505,934,829.17 449,859,335.04
10,000,000.00 10,000,000.00 10,000,000.00 10,000,000.00
309,926,750.00 309,926,750.00 309,926,750.00 309,926,750.00
100.00 100.00 100.00 100.00
3,099,267.50 3,099,267.50 3,099,267.50 3,099,267.50
2,420,482.65 -3,676,942.23 48,190,843.62 50,763,319.16
590,792,019.28 584,694,594.41 636,562,380.25 639,134,855.80
1,348.61 1,228.49 1,409.16 1,482.99
 
 
1,337,498,191.71 640,886,564.82 346,228,917.23 123,449,146.81
999,930,881.20 447,051,770.30 222,170,432.16 76,325,515.80
337,567,310.51 193,834,794.52 124,058,485.07 47,123,631.00
-32,306,089.21 -60,031,112.95 -3,322,533.29 -11,350,406.77
-30,726,658.04 19,356,492.48 -7,775,192.86 4,094,539.16
-63,032,747.25 -79,387,605.43 -11,097,726.15 -15,444,945.93
-8,810,151.95 -18,219,762.83 -1,797,850.07 -4,479,107.73
-54,222,344.14 -61,167,471.32 -9,299,685.47 -10,965,721.42
153.00 0.00 260.00 315.00
 
 
-17.50 -26.31 -6.00 -14.15
190.62 188.66 205.39 206.22
 
 
1.19 1.18 0.79 0.70
-4.19 -6.40 -1.63 -4.03
-9.18 -13.95 -2.92 -6.86
-4.05 -9.54 -2.69 -8.88
-2.42 -9.37 -0.96 -9.19
0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00
 
 
-141,616,973.09 -325,454,045.11 -237,223,951.00 -154,502,423.29
-35,843,492.48 -22,743,097.86 -15,744,251.96 -1,043,779.19
118,960,184.53 198,458,445.36 86,492,988.85 23,559,655.12
-58,500,281.04 -149,738,697.60 -166,475,214.11 -131,986,547.36
194,902,805.97 194,902,805.97 194,902,805.97 194,902,805.97
121,432,026.24 40,873,166.27 29,193,376.68 64,541,814.90